
GGBXF
Healthcare · Drug Manufacturers - Specialty & Generic · $2,061 market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Mar 31, 2020
EPS trend, 90 days to now · +100.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Feb 24, 2020 | After the close | -0.11 | -0.13 | -18.2% |
| Nov 25, 2019 | After the close | -0.02 | -0.15 | -661.5% |
| May 29, 2019 | Before the open | — | -0.07 | — |
| Feb 27, 2019 | After the close | — | -0.08 | — |
| Sep 30, 2018 | Time not confirmed | — | -0.02 | — |
| Jun 30, 2018 | Time not confirmed | — | -0.01 | — |
Green Growth Brands Inc., together with its subsidiaries, engages in the cultivation, processing, production, distribution, and retailing of cannabis and cannabidiol (CBD)-infused consumer products in the United States. It provides medical and retail marijuana products to various dispensaries and CBD-infused personal care and beauty products, such as therapeutic, face care, body care, shower and bathroom, and sleep…